Topic: generic drugs

Introduction to Biosimilars Biosimilars are biologic medical products that are developed to be similar to an already approved biologic drug, known as the reference product or originator biologic. Biosimilars contain similar active ingredients to the originator biologic and rely on similar manufacturing processes to that of the originator. However, biosimilars are not considered to be generics, as biologics tend to be much larger and more complex molecules than conventional small molecule drug...

Market Dynamics: Rising Demand for Generic Drugs: As mentioned in the heading, rising demand for generic drugs is one of the key drivers of India and Oman pharmaceutical industry market growth. Generic drugs offer significant cost savings compared to their branded counterparts. They account for around 80% of the total drugs sold in India and Oman. This has made healthcare more affordable and widened access to medicines. The cost savings offered by generic drugs continue to drive their demand ...

The global Generic Drugs Market was estimated to be US$ 566.85 Billion in 2022 and is expected to increase at a CAGR of 5.7% between 2023 to 2032. The Global Generic Drugs Market Report includes information about significant companies, marketing strategies, and product portfolios to help businesses make informed decisions. The study provides a comprehensive overview of the Generic Drugs market according to product segments, sectors, and regions around the world. It also provides a summary ...